Aortic stenosis cost-effectiveness of therapy: Difference between revisions
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{| class="infobox" style="float:right;" | |||
|- | |||
| [[File:Siren.gif|30px|link=Aortic stenosis resident survival guide]]|| <br> || <br> | |||
| [[Aortic stenosis resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']] | |||
|} | |||
{{Aortic stenosis}} | {{Aortic stenosis}} | ||
{{CMG}} | {{CMG}} | ||
Revision as of 17:23, 2 January 2015
 |
Resident Survival Guide |
|
Aortic Stenosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Percutaneous Aortic Balloon Valvotomy (PABV) or Aortic Valvuloplasty |
|
Transcatheter Aortic Valve Replacement (TAVR) |
|
Case Studies |
|
Aortic stenosis cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Aortic stenosis cost-effectiveness of therapy |
|
Directions to Hospitals Treating Aortic stenosis cost-effectiveness of therapy |
|
Risk calculators and risk factors for Aortic stenosis cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Transcatheter aortic valve implantation (TAVI) is more cost-effective compared to medical management among aortic stenosis patients unsuitable for surgery. Among patients suitable for surgery, surgical aortic valve replacement is more cost-effective than TAVI.[1]
References
- ↑ Orlando R, Pennant M, Rooney S, Khogali S, Bayliss S, Hassan A; et al. (2013). "Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation". Health Technol Assess. 17 (33): 1–86. doi:10.3310/hta17330. PMID 23948359.